TherapeuticsMD (TXMD) Other Gross PP&E Adjustments (2016 - 2025)
TherapeuticsMD (TXMD) has disclosed Other Gross PP&E Adjustments for 15 consecutive years, with -$5.6 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Other Gross PP&E Adjustments rose 12.3% year-over-year to -$5.6 million, compared with a TTM value of -$5.6 million through Sep 2025, up 12.3%, and an annual FY2024 reading of -$6.1 million, up 9.88% over the prior year.
- Other Gross PP&E Adjustments was -$5.6 million for Q3 2025 at TherapeuticsMD, up from -$6.0 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at -$4.2 million in Q3 2022 and bottomed at -$10.6 million in Q2 2021.
- Average Other Gross PP&E Adjustments over 5 years is -$6.0 million, with a median of -$6.0 million recorded in 2025.
- The sharpest move saw Other Gross PP&E Adjustments surged 58.64% in 2022, then crashed 37.82% in 2024.
- Year by year, Other Gross PP&E Adjustments stood at -$8.0 million in 2021, then skyrocketed by 36.87% to -$5.1 million in 2022, then crashed by 33.89% to -$6.8 million in 2023, then rose by 9.88% to -$6.1 million in 2024, then increased by 8.03% to -$5.6 million in 2025.
- Business Quant data shows Other Gross PP&E Adjustments for TXMD at -$5.6 million in Q3 2025, -$6.0 million in Q2 2025, and -$6.2 million in Q1 2025.